Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls.
about
Smoke, Smoke, Smoke That CigaretteGenetics of schizophrenia and smoking: an approach to studying their comorbidity based on epidemiological findingsTobacco use among those with serious psychological distress: results from the national survey of drug use and health, 2002Smoking cessation and reduction in people with chronic mental illnessCognitive Dysfunction, Affective States, and Vulnerability to Nicotine Addiction: A Multifactorial PerspectiveNegative affective states and cognitive impairments in nicotine dependenceEffects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia.Predictors of early abstinence in smokers with schizophreniaHigher nicotine levels in schizophrenia compared with controls after smoking a single cigaretteEffects of smoking abstinence, smoking cues and nicotine replacement in smokers with schizophrenia and controls.Reduced nicotine product standards for combustible tobacco: building an empirical basis for effective regulation.Lower task persistence in smokers with schizophrenia as compared to non-psychiatric control smokersSchizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits.Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar DisorderCigarette smoking is associated with thinner cingulate and insular cortices in patients with severe mental illnessAlpha7 nicotinic acetylcholine receptors modulate motivation to self-administer nicotine: implications for smoking and schizophrenia.Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia.Illicit drug use in heavy smokers with and without schizophrenia.Peer Supports for Tobacco Cessation for Adults with Serious Mental Illness: A Review of the Literature.Rapid smoking may not be aversive in schizophrenia.Separate and combined effects of very low nicotine cigarettes and nicotine replacement in smokers with schizophrenia and controlsSmoking cessation in patients with psychiatric disordersTask persistence predicts smoking cessation in smokers with and without schizophreniaEffects of smoking abstinence on smoking-reinforced responding, withdrawal, and cognition in adults with and without attention deficit hyperactivity disorder.Cigarette demand and delayed reward discounting in nicotine-dependent individuals with schizophrenia and controls: an initial study.Nicotine intake and smoking topography in smokers with bipolar disorderVariants in the 15q25 gene cluster are associated with risk for schizophrenia and bipolar disorder.Shorter interpuff interval is associated with higher nicotine intake in smokers with schizophreniaHealth status of individuals with serious mental illness.Smoking topography and outcome expectancies among individuals with schizotypy.High-affinity nicotinic acetylcholine receptor expression and trafficking abnormalities in psychiatric illnessCigarette Smoking and Health Characteristics in Individuals With Serious Mental Illness Enrolled in a Behavioral Weight Loss Trial.Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behavior, topography, and nicotine levels in smokers with and without schizophrenia: a preliminary study.Reconciling human smoking behavior and machine smoking patterns: implications for understanding smoking behavior and the impact on laboratory studies.Smoking expectancies and intention to quit in smokers with schizophrenia, schizoaffective disorder and non-psychiatric controlsThe role of antipsychotics in smoking and smoking cessation.A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia.Neurocognitive endophenotypes in schizophrenia: modulation by nicotinic receptor systemsDiverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation.ADHD symptoms impact smoking outcomes and withdrawal in response to Varenicline treatment for smoking cessation.
P2860
Q22242313-A3EB3BB8-767B-41E3-A4E4-7B14D1A9DF38Q24289498-0B51F211-015F-4233-9263-24C854C606CDQ24646001-0B232B43-8E79-4EC9-888E-CE7B344BCAB3Q26782639-E51D987D-E2C9-49A6-8E69-D3059DD357D6Q28071876-C30006B3-7CCA-428A-B95F-E828CE71766CQ30371220-58E6A828-0BA9-440C-9B1E-7B797796527DQ30435496-98287B7B-49C7-4AE3-831D-C30B484A333EQ33679772-D80A3E9A-52A0-4267-B1E7-726FA08EA871Q34023532-F45A9AB4-4333-4390-91BB-2CB012BA951BQ34186224-EEA109F3-F274-4ED1-8539-EAB4E18EA52AQ34621879-2B547E80-6C34-45F3-928E-295CF8A5CC5DQ34682158-0D178E9B-086E-4CCE-8185-5A1C4E6F4C3AQ35048154-C774D458-E827-4F7F-81CA-C62475B5C566Q35196495-697DFACF-702C-4C42-86EB-67C3F9FD7E9EQ35772079-B27CA380-3026-4133-B5AB-4CC9ED3C67CDQ35837691-8647FF57-8B64-4D3D-B32F-A157D6864562Q35880018-0899EF03-5F6F-45AD-B7DE-AC22CA706628Q36087073-072060A3-043B-4F30-844C-D2B40BB06A40Q36165689-DE6656E6-E576-409D-9E05-6B5C70E27D9BQ36471911-5FD74769-B125-48C2-87B5-8F28305770A1Q36471948-F0757EA8-C3CC-473F-8F82-78377D63AA5FQ36474143-C926805A-68AB-46E4-99DB-D3CF4621BD30Q36708830-63A7AD0B-4248-4359-B79A-D939F2BDF137Q36759490-E0060B11-CC0A-425E-BA5B-F78A6017D292Q36807511-8F3BE480-D5AE-4145-A9A3-58031E893FA9Q36810188-A06D98E5-CE77-4BD8-AF20-7CB2999C1205Q36817544-99BACF37-BFB5-4CEF-9397-DFE17B01ABC4Q36848924-AF51A166-DC91-4D45-AC99-937915C14976Q37075921-77C705AC-6041-4987-8DCD-851FE38248B5Q37141290-4A09F2FE-86BB-40B6-BCA6-351A791AA454Q37154489-76657F7A-5DB5-4CD6-A0B2-96E01245E0C6Q37190653-5E93DDF0-7D6A-45CC-92A5-97CEC9795163Q37442261-05DF79D3-6DA9-4BCF-95FB-20BB49BF1F94Q37461696-72D44A3A-FFA4-442A-8565-68D4CBB5821EQ37481586-27FFA340-DFA4-4DF8-B3A3-6DAF0986DF1AQ37855779-0ABAC485-EC49-4A76-B4E7-F62FAF4AECA7Q37962995-D9C3A0AE-0418-4753-BD72-92F2CE197E87Q38122913-A3557D71-1A77-4F6E-AE9D-BECAB6B1C04FQ38204497-94BCED6C-A66C-470B-99C7-5917FC641D05Q38664612-179B9DF6-9BC2-4A1D-9181-83E540877CFA
P2860
Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Cigarette smoking topography i ...... ched non-psychiatric controls.
@en
Cigarette smoking topography i ...... ched non-psychiatric controls.
@nl
type
label
Cigarette smoking topography i ...... ched non-psychiatric controls.
@en
Cigarette smoking topography i ...... ched non-psychiatric controls.
@nl
prefLabel
Cigarette smoking topography i ...... ched non-psychiatric controls.
@en
Cigarette smoking topography i ...... ched non-psychiatric controls.
@nl
P2093
P1476
Cigarette smoking topography i ...... ched non-psychiatric controls.
@en
P2093
Damaris J Rohsenow
Gary B Kaplan
Jennifer W Tidey
Robert M Swift
P304
P356
10.1016/J.DRUGALCDEP.2005.04.002
P577
2005-11-01T00:00:00Z